Paul Mahon serves as the Executive Vice President and General Counsel at United Therapeutics Corporation, a biotechnology company focused on developing innovative therapies for chronic and life-threatening conditions. In his role, Mahon is responsible for overseeing the company's legal affairs, ensuring compliance with regulations, and providing strategic guidance to the executive team. His expertise in corporate governance and intellectual property law has been instrumental in navigating the complex landscape of the biotechnology industry. Before joining United Therapeutics, Mahon built a distinguished career in the legal field, with a focus on life sciences and pharmaceuticals. He previously worked at prominent law firms, where he represented clients in high-stakes litigation and provided counsel on a wide range of legal matters. Mahon's deep understanding of the regulatory environment and his ability to develop effective legal strategies have made him a valuable asset to United Therapeutics. Under his leadership, the company has successfully protected its intellectual property and maintained a strong position in the competitive biotechnology market. Mahon's contributions to United Therapeutics extend beyond his legal expertise. He has played a key role in the company's mission to develop groundbreaking therapies that improve patients' lives. His dedication to the company's values and his collaborative approach have earned him the respect of his colleagues and the broader industry. As United Therapeutics continues to innovate and expand its portfolio of treatments, Mahon's strategic guidance and commitment to excellence will remain essential to the company's success.